58 Biggest Movers From Yesterday

Gainers

• XPEL, Inc. XPEL shares jumped 30.8% to close at $14.14 on Monday after reporting strong Q3 results.
• 89bio, Inc. ETNB gained 30% to close at $20.80. 89bio priced its IPO at $16 per share.
• Cabaletta Bio, Inc. CABA rose 25.2% to close at $13.92.
• Carbonite, Inc. CARB shares jumped 24.7% to close at $22.95 on Monday after the company announced it would be acquired by OpenText for $23 per share in cash.
• Nine Energy Service, Inc. NINE shares gained 21.3% to close at $5.97
• Taronis Technologies, Inc. TRNX shares climbed 18.8% to close at $2.09 on Monday.
• Liquid Media Group Ltd. YVR rose 18.1% to close at $2.54.
• Leaf Group Ltd. LEAF gained 17.7% to close at $4.92.
• TransEnterix, Inc. TRXC shares rose 17.5% to close at $0.2663 after the company announced that Anthony Fernando was appointed as the new President and CEO.
• Jounce Therapeutics, Inc. JNCE shares gained 15.8% to close at $4.70.
• Entercom Communications Corp. ETM gained 13.2% to close at $4.89 on continued momentum after the company reported better-than-expected Q3 EPS and sales results.
• InMode Ltd. INMD shares climbed 12.3% to close at $45.41 on continued upward momentum. The stock has increased roughly 210% since its IPO in August 7.
• Dawson Geophysical Company DWSN gained 11.7% to close at $2.78.
• Applied Optoelectronics, Inc. AAOI surged 11.7% to close at $12.15.
• U.S. Auto Parts Network, Inc. PRTS jumped 11.7% to close at $2.49.
• Qurate Retail, Inc. QRTEA rose 11.4% to close at $10.47 after the company reported better-than-expected Q3 EPS results.
• Constellation Pharmaceuticals, Inc. CNST gained 11.2% to close at $34.38.
• The Trade Desk, Inc. TTD rose 11% to close at $217.01 on continued momentum after the company reported better-than-expected Q3 EPS and sales results. The company also had raised its FY19 sales guidance above analyst estimates.
• Titan International, Inc. TWI gained 10.9% to close at $3.06.
• Aquestive Therapeutics, Inc. AQST shares jumped 10.8% to close at $5.99.
• Calumet Specialty Products Partners, L.P. CLMT jumped 10.6% to close at $3.76 after the company reported strategic divestiture of San Antonio Refinery, related assets to Starlight for $63 million in cash.
• PCTEL, Inc. PCTI shares rose 10.3% to close at $9.03.
• Prevail Therapeutics Inc. PRVL shares surged 10% to close at $13.53.
• Switch, Inc. SWCH gained 10% to close at $15.57. Credit Suisse maintained Switch with an Outperform and raised the price target from $18 to $19.
• Genie Energy Ltd. GNE gained 9.7% to close at $7.90.
• Medifast, Inc. MED shares gained 8.4% to close at $80.57.
• CENTOGENE B.V. CNTG shares gained 7.2% to close at $13.92.
• Walgreens Boots Alliance, Inc. WBA climbed 5.1% to close at $62.25 following a media report KKR is considering buying the company.
• Internet Gold - Golden Lines Ltd. IGLD rose 5.1% to close at $12.86 after falling 12.57% on Friday.

Losers

• Lipocine Inc. LPCN shares dipped 70.7% to close at $0.80 on Monday after an adverse FDA verdict on its lead drug Tlando, previously known as LPCN 1021. Lipocine said Monday the FDA said "nay" for the third time for its Tlando, an oral testosterone replacement therapy for use in adult males for treating conditions associated with hypogonadism, which is a deficiency of endogenous testosterone. The complete response letter, or CRL, issued by the FDA signaling the application cannot be approved in the present form, pointed to one deficiency — the efficacy trial not meeting the three secondary endpoints for maximal testosterone concentration. The CRL, however, did not identify issues related to chemistry, manufacturing and controls.
• ASLAN Pharmaceuticals Limited ASLN dropped 68% to close at $0.6660 after the company reported that the TreeTopp global pivotal study of varlitinib in biliary tract cancer did not meet its co-primary endpoint.
• NextCure, Inc. NXTC dropped 52.9% to close at $39.02 after the company announced a 44% patient discontinuation rate in its NC318 Phase 1/2 clinical trial.
• RAPT Therapeutics, Inc. RAPT shares fell 30.3% to close at $19.60.
• TimkenSteel Corporation TMST dropped 25.7% to close at $5.47.
• Foamix Pharmaceuticals Ltd. FOMX fell 19.8% to close at $3.48. Foamix Pharmaceuticals and Menlo Therapeutics Inc. MNLO reported a merger agreement to create a combined biopharmaceutical company. Foamix Pharmaceuticals also reported worse-than-expected Q3 EPS results.
• 36KR HOLDINGS INC. KRKR fell 17.8% to close at $10.74.
• Neptune Wellness Solutions Inc. NEPT dropped 16.7% to close at $2.95 after the company reported second-quarter revenue of CA$6.51 million ($4.9 million)on Monday and announced a partnership with International Flavors & Fragrances Inc. IFF.
• Assembly Biosciences, Inc. ASMB shares declined 15.2% to close at $14.48.
• Applied DNA Sciences, Inc. APDN dipped 15.2% to close at $4.40.
• FibroGen, Inc. FGEN tumbled 14.9% to close at $35.40. FibroGen reported worse-than-expected Q3 EPS results after the closing bell.
• SunCoke Energy, Inc. SXC fell 14.2% to close at $5.15 on continued momentum after the company filed for a mixed shelf offering for up to $750 million.
• Paringa Resources Limited PNRL fell 14% to close at $ 2.15.
• Adient plc ADNT dipped 13.2% to close at $21.24. The stock rallied approximately 8.5% on Q3 earnings and is now trading below its price level before earnings were released.
• Extraction Oil & Gas, Inc. XOG tumbled 12.6% to close at $1.87 as a potential sell-off after the stock increased roughly 38% following the company reported better-than-expected Q3 EPS results last Thursday.
• Airgain, Inc. AIRG dropped 12.1% to close at $10.02.
• Ocular Therapeutix, Inc. OCUL fell 11.8% to close at $2.93 after the company reported strategic update and operational restructuring.
• InnerWorkings, Inc. INWK dipped 10.6% to close at $4.45.
• Summit Midstream Partners, LP SMLP dropped 10.4% to close at $3.96.
• Pacific Drilling S.A. PACD dropped 10.3% to close at $3.14.
• Synthesis Energy Systems, Inc. SES shares declined 10.2% to close at $7.99.
• Akebia Therapeutics, Inc. AKBA dropped 9.9% to close at $3.66.
• Evolent Health, Inc. EVH fell 8.4% to close at $9.27 after climbing 8.47% on Friday.
• Uxin Limited UXIN fell 7.9% to close at $3.15.
• MyoKardia, Inc. MYOK fell 7.6% to close at $55.45.
• NIO Inc. NIO dropped 6.1% to close at $1.86 after the company cut its electric car subsidies. The Chinese car sales have also declined for 16 consecutive months in October.
• CytomX Therapeutics, Inc. CTMX dropped 6.1% to close at $5.59. Wedbush downgraded CytomX Therapeutics from Outperform to Neutral and lowered the price target from $25 to $8.
• Tonix Pharmaceuticals Holding Corp. TNXP shares dropped 6% to close at $2.54 following weak Q3 earnings.
• Scientific Games Corporation SGMS dipped 5.5% to close at $29.83 after Susquehanna downgraded the stock from Positive to Neutral.